Tag: Impavido

Originally developed as an anti-cancer agent, miltefosine was later repurposed to treat leishmaniasis, a parasitic disease. The answer to **What is the generic for miltefosine?** is that miltefosine itself is the generic name for this medication, which is sold under the brand name Impavido.

Miltefosine, the only oral treatment for leishmaniasis, was originally developed as an anticancer agent before being repurposed for parasitic diseases. Knowing how to obtain miltefosine requires navigating a specific set of procedures, including securing a medical prescription, understanding commercial availability, and adhering to strict safety protocols.

Leishmaniasis, a parasitic disease spread by sand fly bites, affects up to 12 million people worldwide. So, **what is Impavido used for?** It is the first and only FDA-approved oral medication for treating specific forms of this challenging disease.

With an estimated 0.7 to 1 million new cases annually, leishmaniasis is a significant global health issue. So, what does Impavido treat? This oral medication is a primary weapon against specific parasitic infections caused by the *Leishmania* parasite and is also used for other rare but deadly infections.

Leishmaniasis is a parasitic disease estimated to affect hundreds of thousands of people annually worldwide, with a historical reliance on injectable treatments. The development of miltefosine, the first and only recognized oral drug for leishmaniasis, marked a significant advancement in therapeutic options for this neglected tropical disease.

First developed as an anticancer agent, miltefosine is now the first and only orally available medication approved by the U.S. FDA to treat various forms of leishmaniasis.